前のページに戻るこの文献は全文を取り寄せることができます

JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。

既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方

JDreamⅢ複写サービス
文献複写のお申込み

JDreamⅢ複写サービスのご利用が初めての方

学術文献の全文複写をお取寄せ
JDreamⅢ複写サービスのご案内

取り寄せる文献のタイトルと詳細

文献

J-GLOBAL ID：201902268194057025 整理番号：19A2242825

がん治療:収斂するMAPK経路の活性化が仲介するTRK阻害抵抗性

Resistance to TRK inhibition mediated by convergent MAPK pathway activation

著者 (45件)：

COCCO Emiliano

(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

RAZAVI Pedram

(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

TOSKA Eneda

(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

COWNIE James

(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

SOMWAR Romel

(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

SHIFMAN Sophie

(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

BERGER Michael F.

(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

LADANYI Marc

(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

SCALTRITI Maurizio

(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

COCCO Emiliano

(Dep. of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

PTASHKIN Ryan

(Dep. of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

HECHTMAN Jaclyn F.

(Dep. of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

SOMWAR Romel

(Dep. of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

SHIFMAN Sophie

(Dep. of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

BERGER Michael F.

(Dep. of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

LADANYI Marc

(Dep. of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

SCALTRITI Maurizio

(Dep. of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

SCHRAM Alison M.

(Dep. of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

YAEGER Rona

(Dep. of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

RAZAVI Pedram

(Dep. of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

HYMAN David M.

(Dep. of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

DRILON Alexander

(Dep. of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

SCHRAM Alison M.

(Weill Cornell Medical Coll., New York, NY, USA)

,

HYMAN David M.

(Weill Cornell Medical Coll., New York, NY, USA)

,

DRILON Alexander

(Weill Cornell Medical Coll., New York, NY, USA)

,

KULICK Amanda

(Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

MISALE Sandra

(Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

YAEGER Rona

(Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

MATTAR Marissa

(Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

GUZMAN Sean

(Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

DE STANCHINA Elisa

(Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

KULICK Amanda

(Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

MATTAR Marissa

(Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

GUZMAN Sean

(Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

WON Helen H.

(Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

DE STANCHINA Elisa

(Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

HOUCK-LOOMIS Brian

(Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

PATEL Juber A.

(Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

BERGER Michael F.

(Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

SELCUKLU S. Duygu

(Dep. of Lab. Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

SAMOILA Aliaksandra

(Dep. of Lab. Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

,

TUCH Brian B.

(Loxo Oncology, South San Francisco, CA, USA)

,

EBATA Kevin

(Loxo Oncology, South San Francisco, CA, USA)

,

NAGY Rebecca J.

(Dep. of Medical Affairs, Guardant Health Inc., Redwood City, CA, USA)

,

LANMAN Richard B.

(Dep. of Medical Affairs, Guardant Health Inc., Redwood City, CA, USA)

資料名：

Nature Medicine (Nature Medicine)

巻： 25 号： 9 ページ： 1422-1427 発行年： 2019年09月
JST資料番号： W0636A ISSN： 1078-8956 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：アメリカ合衆国 (USA) 言語：英語 (EN)

JDreamⅢ複写サービスとは

JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。

TOP

BOTTOM